Sigma Healthcare Limited
Symbol: SIG.AX
ASX
1.295
AUDMarktpreis heute
447.5904
P/E-Verhältnis
3.5707
PEG-Verhältnis
1.95B
MRK Kapital
- 0.01%
DIV Rendite
Sigma Healthcare Limited (SIG-AX) Finanzberichte
Bilanz
common:word.in-mln USD Growth | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 356.5 | 16.6 | 31.1 | |||||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 320 | 337.4 | 358.7 | |||||||||||||||||||||||
balance-sheet.row.inventory | 0 | 221.1 | 324.9 | 321.6 | |||||||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 14.9 | 6.9 | 50.1 | |||||||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 912.5 | 685.8 | 761.6 | |||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 271.8 | 290.9 | 281.6 | |||||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 89.1 | 95.2 | 103 | |||||||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 20 | 118.2 | 128.1 | |||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 109.1 | 213.5 | 231 | |||||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 21.3 | 17.4 | 18.4 | |||||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 88.3 | 89.2 | 85.8 | |||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 1.2 | -95.2 | -103 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 491.6 | 515.8 | 513.8 | |||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.total-assets | 0 | 1404.1 | 1201.6 | 1275.4 | |||||||||||||||||||||||
balance-sheet.row.account-payables | 0 | 303.4 | 406 | 352.3 | |||||||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 9.8 | 12.9 | 25.7 | |||||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 126.8 | 80 | 165 | |||||||||||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 134 | 132.7 | |||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 58 | 57.4 | 77.8 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 160.2 | 246.5 | 329 | |||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 126.8 | 134 | 132.7 | |||||||||||||||||||||||
balance-sheet.row.total-liab | 0 | 531.5 | 723.8 | 786.7 | |||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.common-stock | 0 | 1682.4 | 1286.1 | 1286.1 | |||||||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | -769.2 | -761.6 | -741.1 | |||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 2.9 | 3 | 2.9 | |||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | -45.3 | -51.7 | -60.7 | |||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 870.8 | 475.9 | 487.2 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 1404.1 | 1201.6 | 1275.4 | |||||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 1.8 | 1.8 | 1.6 | |||||||||||||||||||||||
balance-sheet.row.total-equity | 0 | 872.6 | 477.8 | 488.8 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||||||||
Total Investments | 0 | 21.3 | 17.4 | 18.4 | |||||||||||||||||||||||
balance-sheet.row.total-debt | 0 | 136.6 | 227 | 323.4 | |||||||||||||||||||||||
balance-sheet.row.net-debt | 0 | -219.9 | 210.3 | 292.3 |
Kapitalflussrechnung
common:word.in-mln USD Growth | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 4.5 | 1.8 | -7.2 | ||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 28.3 | 30.3 | 27.7 | ||||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -2.8 | 15.2 | -65.7 | ||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 2.8 | 1.9 | 0 | ||||||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | 16.3 | 87.2 | -76.1 | ||||||||||||||||||||||
cash-flows.row.account-receivables | 0 | 10.9 | 27.5 | -30.7 | ||||||||||||||||||||||
cash-flows.row.inventory | 0 | 103.7 | -3.2 | 27.5 | ||||||||||||||||||||||
cash-flows.row.account-payables | 0 | -102.7 | 53.5 | -7.1 | ||||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 4.3 | 9.3 | -65.8 | ||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | -7.2 | 6.3 | 75.1 | ||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -4.7 | -29.4 | -14.2 | ||||||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 8.9 | 0.5 | 0 | ||||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -10.5 | -0.8 | -2.4 | ||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 1.5 | 0.3 | 0 | ||||||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 10.5 | 0.8 | 0 | ||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 5.7 | -28.6 | -16.6 | ||||||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -80 | -85 | -165 | ||||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 396.1 | 0.9 | 0.2 | ||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -9.5 | -16.9 | -165.2 | ||||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -10.8 | -15 | -19.9 | ||||||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | -0.8 | -1 | 478.8 | ||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 295.8 | -116.9 | 128.9 | ||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 339.8 | -14.5 | 15 | ||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 356.5 | 16.6 | 31.1 | ||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 16.6 | 31.1 | 16.1 | ||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 42 | 142.7 | -46.3 | ||||||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -4.7 | -29.4 | -14.2 | ||||||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | 37.2 | 113.3 | -60.5 |
Zeile der Gewinn- und Verlustrechnung
common:word.in-mln USD Growth | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 3322.1 | 3660.2 | 3446.2 | |||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 3132.2 | 3436.2 | 3246.7 | |||||||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 189.8 | 224.1 | 199.4 | |||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 41.4 | 101.7 | 44.7 | |||||||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 261.8 | 293 | 309.6 | |||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 3394 | 3729.2 | 3556.3 | |||||||||||||||||||||||
income-statement-row.row.interest-income | 0 | 1.7 | 0.6 | 0.2 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 16.3 | 14.4 | 10.8 | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 80.6 | 74.4 | 101.9 | |||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 41.4 | 101.7 | 44.7 | |||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 80.6 | 74.4 | 101.9 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 16.3 | 14.4 | 10.8 | |||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 28.3 | 30.3 | 27.7 | |||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.operating-income | 0 | -71.9 | -68.9 | -110.2 | |||||||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 8.6 | 5.5 | -8.3 | |||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 3.3 | 2.4 | -2 | |||||||||||||||||||||||
income-statement-row.row.net-income | 0 | 4.5 | 1.8 | -7.2 |
Häufig gestellte Frage
Wie hoch ist die Sigma Healthcare Limited (SIG.AX) Gesamtvermögen?
Sigma Healthcare Limited (SIG.AX) Gesamtvermögen ist 1404133000.000.
Wie hoch ist der Jahresumsatz des Unternehmens?
Der Jahresumsatz ist N/A.
Wie hoch ist die Gewinnspanne des Unternehmens?
Die Gewinnmarge des Unternehmens ist 0.057.
Wie hoch ist der freie Cashflow des Unternehmens?
Der freie Cashflow ist 0.024.
Wie hoch ist die Nettogewinnspanne des Unternehmens?
Die Nettogewinnmarge ist 0.001.
Wie hoch sind die Gesamteinnahmen des Unternehmens?
Der Gesamtertrag ist -0.022.
Was ist der Sigma Healthcare Limited (SIG.AX) nettogewinn (reingewinn)?
Der Nettogewinn (Nettoeinkommen) ist 4509000.000.
Wie hoch ist die Gesamtverschuldung des Unternehmens?
Die Gesamtverschuldung ist 136631000.000.
Wie hoch ist der Betriebsaufwand?
Die Betriebsausgaben sind 261767000.000.
Wie hoch ist der Bargeldbestand des Unternehmens?
Die Unternehmensliquidität ist 0.000.